BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurevich VV, Gurevich EV. Biased GPCR signaling: Possible mechanisms and inherent limitations. Pharmacol Ther 2020;211:107540. [PMID: 32201315 DOI: 10.1016/j.pharmthera.2020.107540] [Cited by in Crossref: 18] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Erdem Tuncdemir B. Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus. J Recept Signal Transduct Res 2022;:1-7. [PMID: 35901021 DOI: 10.1080/10799893.2022.2102651] [Reference Citation Analysis]
2 Martínez-Morales JC, Solís KH, Romero-Ávila MT, Reyes-Cruz G, García-Sáinz JA. Cell Trafficking and Function of G Protein-coupled Receptors. Arch Med Res 2022;53:451-60. [PMID: 35835604 DOI: 10.1016/j.arcmed.2022.06.008] [Reference Citation Analysis]
3 El Khamlichi C, Reverchon F, Hervouet-Coste N, Robin E, Chopin N, Deau E, Madouri F, Guimpied C, Colas C, Menuet A, Inoue A, Bojarski AJ, Guillaumet G, Suzenet F, Reiter E, Morisset-Lopez S. Serodolin, a β-arrestin-biased ligand of 5-HT7 receptor, attenuates pain-related behaviors. Proc Natl Acad Sci U S A 2022;119:e2118847119. [PMID: 35594393 DOI: 10.1073/pnas.2118847119] [Reference Citation Analysis]
4 Seyedabadi M, Gharghabi M, Gurevich EV, Gurevich VV. Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling. Trends Biochem Sci 2022:S0968-0004(22)00068-8. [PMID: 35396120 DOI: 10.1016/j.tibs.2022.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Li C, Liu J, Chen J, Yuan Y, Yu J, Gou Q, Guo Y, Pu X. An Interpretable Convolutional Neural Network Framework for Analyzing Molecular Dynamics Trajectories: a Case Study on Functional States for G-Protein-Coupled Receptors. J Chem Inf Model 2022. [PMID: 35257580 DOI: 10.1021/acs.jcim.2c00085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Klussmeier A, Aurich S, Niederstadt L, Wiedenmann B, Grötzinger C. Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development. Biomedicines 2022;10:536. [DOI: 10.3390/biomedicines10030536] [Reference Citation Analysis]
7 Madhu MK, Debroy A, Murarka RK. Molecular Insights into Phosphorylation-Induced Allosteric Conformational Changes in a β2-Adrenergic Receptor. J Phys Chem B 2022. [PMID: 35196859 DOI: 10.1021/acs.jpcb.1c08610] [Reference Citation Analysis]
8 Divorty N, Jenkins L, Ganguly A, Butcher AJ, Hudson BD, Schulz S, Tobin AB, Nicklin SA, Milligan G. Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. J Biol Chem 2022;298:101655. [PMID: 35101446 DOI: 10.1016/j.jbc.2022.101655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
9 Pluhackova K, Wilhelm FM, Müller DJ. Lipids and Phosphorylation Conjointly Modulate Complex Formation of β2-Adrenergic Receptor and β-arrestin2. Front Cell Dev Biol 2021;9:807913. [PMID: 35004696 DOI: 10.3389/fcell.2021.807913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wess J. The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models. Int J Mol Sci 2022;23:495. [PMID: 35008921 DOI: 10.3390/ijms23010495] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lin LC, Quon T, Engberg S, Mackenzie AE, Tobin AB, Milligan G. G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes. ACS Pharmacol Transl Sci 2021;4:1835-48. [PMID: 34927014 DOI: 10.1021/acsptsci.1c00224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Chen J, Liu J, Yuan Y, Chen X, Zhang F, Pu X. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor. J Chem Inf Model 2021. [PMID: 34802238 DOI: 10.1021/acs.jcim.1c01016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Karnam PC, Vishnivetskiy SA, Gurevich VV. Structural Basis of Arrestin Selectivity for Active Phosphorylated G Protein-Coupled Receptors. Int J Mol Sci 2021;22:12481. [PMID: 34830362 DOI: 10.3390/ijms222212481] [Reference Citation Analysis]
14 Chandler B, Todd L, Smith SO. Magic angle spinning NMR of G protein-coupled receptors. Progress in Nuclear Magnetic Resonance Spectroscopy 2021. [DOI: 10.1016/j.pnmrs.2021.10.002] [Reference Citation Analysis]
15 Khelifa MS, Skov LJ, Holst B. Biased Ghrelin Receptor Signaling and the Dopaminergic System as Potential Targets for Metabolic and Psychological Symptoms of Anorexia Nervosa. Front Endocrinol (Lausanne) 2021;12:734547. [PMID: 34646236 DOI: 10.3389/fendo.2021.734547] [Reference Citation Analysis]
16 Turu G, Soltész-Katona E, Tóth AD, Juhász C, Cserző M, Misák Á, Balla A, Caron MG, Hunyady L. Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor. Front Endocrinol (Lausanne) 2021;12:714561. [PMID: 34484125 DOI: 10.3389/fendo.2021.714561] [Reference Citation Analysis]
17 Kalinkovich A, Livshits G. Biased and allosteric modulation of bone cell-expressing G protein-coupled receptors as a novel approach to osteoporosis therapy. Pharmacol Res 2021;171:105794. [PMID: 34329703 DOI: 10.1016/j.phrs.2021.105794] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Wanka L, Behr V, Beck-Sickinger AG. Arrestin-dependent internalization of rhodopsin-like G protein-coupled receptors. Biol Chem 2021. [PMID: 34036761 DOI: 10.1515/hsz-2021-0128] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Roy S, Chompunud Na Ayudhya C, Thapaliya M, Deepak V, Ali H. Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease. J Allergy Clin Immunol 2021;148:293-308. [PMID: 33957166 DOI: 10.1016/j.jaci.2021.03.049] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
20 Zhang Y, Shi T, He Y. GPR35 regulates osteogenesis via the Wnt/GSK3β/β-catenin signaling pathway. Biochem Biophys Res Commun 2021;556:171-8. [PMID: 33839412 DOI: 10.1016/j.bbrc.2021.03.084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Che T, Dwivedi-Agnihotri H, Shukla AK, Roth BL. Biased ligands at opioid receptors: Current status and future directions. Sci Signal 2021;14:eaav0320. [PMID: 33824179 DOI: 10.1126/scisignal.aav0320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
22 Aydin Y, Coin I. Biochemical insights into structure and function of arrestins. FEBS J 2021;288:2529-49. [DOI: 10.1111/febs.15811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sulon SM, Benovic JL. Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors. Curr Opin Endocr Metab Res 2021;16:56-65. [PMID: 33718657 DOI: 10.1016/j.coemr.2020.09.002] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Fuentes N, McCullough M, Panettieri RA Jr, Druey KM. RGS proteins, GRKs, and beta-arrestins modulate G protein-mediated signaling pathways in asthma. Pharmacol Ther 2021;223:107818. [PMID: 33600853 DOI: 10.1016/j.pharmthera.2021.107818] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Seyedabadi M, Gharghabi M, Gurevich EV, Gurevich VV. Receptor-Arrestin Interactions: The GPCR Perspective. Biomolecules 2021;11:218. [PMID: 33557162 DOI: 10.3390/biom11020218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
26 Ricarte A, Dalton JAR, Giraldo J. Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns. J Chem Inf Model 2021;61:1251-74. [PMID: 33448226 DOI: 10.1021/acs.jcim.0c00890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gurevich EV, Gurevich VV. GRKs as Modulators of Neurotransmitter Receptors. Cells 2020;10:E52. [PMID: 33396400 DOI: 10.3390/cells10010052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 Pydi SP, Barella LF, Meister J, Wess J. Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models. Trends Endocrinol Metab 2021;32:118-29. [PMID: 33358450 DOI: 10.1016/j.tem.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Rassias G, Leonardi S, Rigopoulou D, Vachlioti E, Afratis K, Piperigkou Z, Koutsakis C, Karamanos NK, Gavras H, Papaioannou D. Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved? Eur J Med Chem 2021;210:112948. [PMID: 33139111 DOI: 10.1016/j.ejmech.2020.112948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
30 Dengler DG, Sun Q, Holleran J, Pollari S, Beutel J, Brown BT, Shinoki Iwaya A, Ardecky R, Harikumar KG, Miller LJ, Sergienko EA. Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors. SLAS Discov 2021;26:1-16. [PMID: 32749201 DOI: 10.1177/2472555220945284] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Quon T, Lin LC, Ganguly A, Tobin AB, Milligan G. Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35. ACS Pharmacol Transl Sci 2020;3:801-12. [PMID: 33073184 DOI: 10.1021/acsptsci.0c00079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
32 Fernandez TJ, De Maria M, Lobingier BT. A cellular perspective of bias at G protein-coupled receptors. Protein Sci 2020;29:1345-54. [PMID: 32297394 DOI: 10.1002/pro.3872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Sussman CR, Wang X, Chebib FT, Torres VE. Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling. Cell Signal 2020;72:109649. [PMID: 32335259 DOI: 10.1016/j.cellsig.2020.109649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]